HepBest（Vemlidy）Tenofovir Alafenamide 25mg online
HepBest (Vemlidy) is a hepatitis B virus (HBV) nucleoside analog reverse transcriptase inhibitor and is indicated for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease.
DOSAGE AND ADMINISTRATION
1. Testing: Prior to initiation of HepBest, test patients for HIV infection. HepBest alone should not be used in patients with HIV infection. Assess serum creatinine, serum phosphorous, estimated creatinine clearance, urine glucose, and urine protein before initiating HepBest and during therapy in all patients as clinically appropriate.
2. Recommended dosage: 25 mg (one tablet) taken orally once daily with food.
3. Renal Impairment: HepBest is not recommended in patients with estimated creatinine clearance below 15 mL per minute
4. Hepatic Impairment: HepBest is not recommended in patients with decompensated (Child-Pugh B or C) hepatic impairment.
HepBest’s brand name is Vemlidy® by Gilead. HepBest is a generic hepatitis B virus prescription medicine from Mylan, which is one of the biggest pharmaceutical company in India.
For more Prescribing information，please check the → “FDA Prescribing Information”.
